Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company RegenxBio Inc.
DescriptionAdeno-associated virus serotype 8 (AAV8) vector that carries a gene for a mAb fragment which binds to VEGF and neutralizes VEGF activity
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today